The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
Clinical trial NCT05759208 · COMPLETED
Trial details
- NCT number
- NCT05759208
- Sponsor
- Okyo Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-28
- Primary completion
- 2023-12-15
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.